Search research articles
Contact Us
Filters
Showing results (161-170 of 184) with videos related to
Page
of 19
Sort By:
ACS Applied Materials & Interfaces
|
January 18, 2020
High Heat Flux Evaporation of Low Surface Tension Liquids from Nanoporous Membranes
Daniel F Hanks, Zhengmao Lu, Jay Sircar, et al.
Sante (Montrouge, France)
|
January 1, 1997
[The development of public health education: the Mauritius experience]
R Salamon, C Lanièce, G Daby, et al.
L'Encephale
|
April 17, 1999
[Evaluation of the incidence of hospitalization of patients with psychotic disorders]
C Bergey, H Verdoux, F Assens, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 1, 1997
Increased risk of toxoplasmic encephalitis in human immunodeficiency virus-infected patients with pyrimethamine-related rash. ANRS 005-ACTG 154 Trial Group. Agence Nationale de Recherche sur le SIDA (ANRS-INSERM) and the NIAID-AIDS Clinical Trials Group
F Rousseau, S Pueyo, P Morlat, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
July 27, 2001
Clinical, biologic, and behavioral predictors of early immunologic and virologic response in HIV-infected patients initiating protease inhibitors
V Le Moing, G Chêne, M P Carrieri, et al.
The Journal of Infectious Diseases
|
January 1, 1996
Pyrimethamine for primary prophylaxis of toxoplasmic encephalitis in patients with human immunodeficiency virus infection: a double-blind, randomized trial. ANRS 005-ACTG 154 Group Members. Agence Nationale de Recherche sur le SIDA. AIDS Clinical Trial Group
C Leport, G Chêne, P Morlat, et al.
Controlled Clinical Trials
|
June 10, 1998
Intention-to-treat vs. on-treatment analyses of clinical trial data: experience from a study of pyrimethamine in the primary prophylaxis of toxoplasmosis in HIV-infected patients. ANRS 005/ACTG 154 Trial Group
G Chêne, P Morlat, C Leport, et al.
Revue D'Epidemiologie Et De Sante Publique
|
February 5, 2013
[The role of a hospital-based registry of a regional cancer center for a population-based cancer registry]
F Colombani, E Pereira, J Bettaieb, et al.
La Revue De Medecine Interne
|
January 1, 1997
[Prevalence of clinical manifestations of allergic reactions in HIV infection. Cross sectional study of 115 subjects]
C Rancinan, P Morlat, G Chêne, et al.
Bulletin De La Societe De Pathologie Exotique (1990)
|
July 30, 2005
[Profile of HIV infected patients among blood donors in Abidjan, Côte d'Ivoire (1992-1999)]
A K Minga, C Huët, I Coulibaly, et al.
Page
of 19
Search research articles
Search
Showing results (161-170 of 184) with videos related to
Sort By:
Page
of 19
ACS Applied Materials & Interfaces
|
January 18, 2020
High Heat Flux Evaporation of Low Surface Tension Liquids from Nanoporous Membranes
Daniel F Hanks, Zhengmao Lu, Jay Sircar, et al.
Sante (Montrouge, France)
|
January 1, 1997
[The development of public health education: the Mauritius experience]
R Salamon, C Lanièce, G Daby, et al.
L'Encephale
|
April 17, 1999
[Evaluation of the incidence of hospitalization of patients with psychotic disorders]
C Bergey, H Verdoux, F Assens, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 1, 1997
Increased risk of toxoplasmic encephalitis in human immunodeficiency virus-infected patients with pyrimethamine-related rash. ANRS 005-ACTG 154 Trial Group. Agence Nationale de Recherche sur le SIDA (ANRS-INSERM) and the NIAID-AIDS Clinical Trials Group
F Rousseau, S Pueyo, P Morlat, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
July 27, 2001
Clinical, biologic, and behavioral predictors of early immunologic and virologic response in HIV-infected patients initiating protease inhibitors
V Le Moing, G Chêne, M P Carrieri, et al.
The Journal of Infectious Diseases
|
January 1, 1996
Pyrimethamine for primary prophylaxis of toxoplasmic encephalitis in patients with human immunodeficiency virus infection: a double-blind, randomized trial. ANRS 005-ACTG 154 Group Members. Agence Nationale de Recherche sur le SIDA. AIDS Clinical Trial Group
C Leport, G Chêne, P Morlat, et al.
Controlled Clinical Trials
|
June 10, 1998
Intention-to-treat vs. on-treatment analyses of clinical trial data: experience from a study of pyrimethamine in the primary prophylaxis of toxoplasmosis in HIV-infected patients. ANRS 005/ACTG 154 Trial Group
G Chêne, P Morlat, C Leport, et al.
Revue D'Epidemiologie Et De Sante Publique
|
February 5, 2013
[The role of a hospital-based registry of a regional cancer center for a population-based cancer registry]
F Colombani, E Pereira, J Bettaieb, et al.
La Revue De Medecine Interne
|
January 1, 1997
[Prevalence of clinical manifestations of allergic reactions in HIV infection. Cross sectional study of 115 subjects]
C Rancinan, P Morlat, G Chêne, et al.
Bulletin De La Societe De Pathologie Exotique (1990)
|
July 30, 2005
[Profile of HIV infected patients among blood donors in Abidjan, Côte d'Ivoire (1992-1999)]
A K Minga, C Huët, I Coulibaly, et al.
Page
of 19